DPPA2 anticorps (N-Term)
Aperçu rapide pour DPPA2 anticorps (N-Term) (ABIN630962)
Antigène
Voir toutes DPPA2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- DPPA2 antibody was raised against the N terminal of DPPA2
-
Purification
- Affinity purified
-
Immunogène
- DPPA2 antibody was raised using the N terminal of DPPA2 corresponding to a region with amino acids NMEQMEPSVSSTSDVKLEKPKKYNPGHLLQTNEQFTAPQKARCKIPALPL
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
DPPA2 Blocking Peptide, (ABIN5613250), is also available for use as a blocking control in assays to test for specificity of this DPPA2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DPPA2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DPPA2 (Developmental Pluripotency Associated 2 (DPPA2))
-
Autre désignation
- DPPA2
-
Sujet
- DPPA2 may play a role in maintaining cell pluripotentiality. ECSA/DPPA2 is a promising target for antigen-specific immunotherapy in non-small cell lung cancers.
-
Poids moléculaire
- 34 kDa (MW of target protein)
-
Pathways
- Stem Cell Maintenance
Antigène
-